Marek Woynarowski

1.8k total citations
46 papers, 767 citations indexed

About

Marek Woynarowski is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Marek Woynarowski has authored 46 papers receiving a total of 767 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Epidemiology, 22 papers in Hepatology and 17 papers in Surgery. Recurrent topics in Marek Woynarowski's work include Liver Disease Diagnosis and Treatment (12 papers), Hepatitis B Virus Studies (11 papers) and Hepatitis C virus research (11 papers). Marek Woynarowski is often cited by papers focused on Liver Disease Diagnosis and Treatment (12 papers), Hepatitis B Virus Studies (11 papers) and Hepatitis C virus research (11 papers). Marek Woynarowski collaborates with scholars based in Poland, Germany and United States. Marek Woynarowski's co-authors include Michael P. Manns, Markus Pröls, Christian P. Strassburg, Józef Ryżko, Jerzy Socha, Piotr Socha, Ulrich Spengler, Wolfgang Kreisel, Mathias Bähr and Christian Rust and has published in prestigious journals such as Gastroenterology, Hepatology and The Journal of Infectious Diseases.

In The Last Decade

Marek Woynarowski

43 papers receiving 743 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marek Woynarowski Poland 14 485 472 315 93 66 46 767
Fuad Hasan Kuwait 17 738 1.5× 641 1.4× 205 0.7× 137 1.5× 42 0.6× 59 1.1k
Alberto Muñoz Argentina 14 490 1.0× 527 1.1× 181 0.6× 43 0.5× 56 0.8× 26 748
Ranjana Gondal India 16 295 0.6× 241 0.5× 274 0.9× 36 0.4× 66 1.0× 65 754
Mustafa Yakut Türkiye 12 291 0.6× 242 0.5× 154 0.5× 82 0.9× 23 0.3× 34 550
Breanndan S. Moore United States 6 342 0.7× 604 1.3× 432 1.4× 98 1.1× 86 1.3× 7 924
Mirta Ciocca Argentina 15 723 1.5× 883 1.9× 303 1.0× 52 0.6× 157 2.4× 57 1.1k
A. Elewaut Belgium 11 239 0.5× 186 0.4× 153 0.5× 98 1.1× 38 0.6× 38 504
Mohammed Q. Khan Saudi Arabia 16 270 0.6× 229 0.5× 158 0.5× 52 0.6× 14 0.2× 31 507
Gökhan Kabaçam Türkiye 11 810 1.7× 690 1.5× 156 0.5× 77 0.8× 24 0.4× 39 1.0k
Zsuzsanna Vitális Hungary 13 352 0.7× 289 0.6× 109 0.3× 135 1.5× 25 0.4× 34 544

Countries citing papers authored by Marek Woynarowski

Since Specialization
Citations

This map shows the geographic impact of Marek Woynarowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Woynarowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Woynarowski more than expected).

Fields of papers citing papers by Marek Woynarowski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marek Woynarowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Woynarowski. The network helps show where Marek Woynarowski may publish in the future.

Co-authorship network of co-authors of Marek Woynarowski

This figure shows the co-authorship network connecting the top 25 collaborators of Marek Woynarowski. A scholar is included among the top collaborators of Marek Woynarowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek Woynarowski. Marek Woynarowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Woynarowski, Marek, et al.. (2023). Increased aminotransferases do not necessarily mean hepatotoxicity of CFTR modulator therapy. Clinical and Experimental Hepatology. 9(4). 405–409.
2.
Sands, Dorota, et al.. (2022). Improving nutrition in cystic fibrosis: A systematic literature review. Nutrition. 102. 111725–111725. 7 indexed citations
3.
Lytton, Simon D., Božena Cukrowská, Aldona Wierzbicka, et al.. (2019). Tryptophan-kynurenine profile in pediatric autoimmune hepatitis. Immunologic Research. 67(1). 39–47. 13 indexed citations
4.
Pytrus, Tomasz, et al.. (2019). New colon anatomy-related ratios used to predict the course of colonoscopy in children. Advances in Clinical and Experimental Medicine. 28(12). 1627–1632. 1 indexed citations
5.
Kowalska‐Duplaga, Kinga, Katarzyna Karolewska‐Bochenek, Marek Woynarowski, et al.. (2017). Solitary Rectal Ulcer Syndrome in Children: A Case Series Study. Advances in experimental medicine and biology. 1020. 105–112. 9 indexed citations
6.
Oracz, Grzegorz, Agnieszka Sobczyńska‐Tomaszewska, Maciej Dądalski, et al.. (2016). The clinical course of hereditary pancreatitis in children – A comprehensive analysis of 41 cases. Pancreatology. 16(4). 535–541. 13 indexed citations
7.
Sieczkowska, Joanna, et al.. (2016). Esophageal achalasia in children. Postępy Nauk Medycznych.
8.
Jurkiewicz, Elżbieta, Maciej Dądalski, Jarosław Kierkuś, et al.. (2016). MRCP Versus ERCP in the Evaluation of Chronic Pancreatitis in Children. Pancreas. 45(8). 1115–1119. 24 indexed citations
9.
Dądalski, Maciej, et al.. (2014). Fecal calprotectin is a good biomarker of mucosal healing in monitoring of children with IBD. Postępy Nauk Medycznych. 3 indexed citations
10.
Kierkuś, Jarosław, et al.. (2014). Comparative Safety and Efficacy of Proton Pump Inhibitors in Paediatric Gastroesophageal Reflux Disease. Drug Safety. 37(5). 309–316. 4 indexed citations
11.
Woynarowski, Marek. (2014). Nasogastric tube as protection for recurrent oesophageal stricture: A case report. World Journal of Gastroenterology. 20(16). 4806–4806. 4 indexed citations
12.
Woynarowski, Marek, Antal Németh, Yaacov Baruch, et al.. (2013). Budesonide versus Prednisone with Azathioprine for the Treatment of Autoimmune Hepatitis in Children and Adolescents. The Journal of Pediatrics. 163(5). 1347–1353.e1. 75 indexed citations
13.
Kierkuś, Jarosław, Maciej Dądalski, Edyta Szymańska, et al.. (2012). The impact of infliximab induction therapy on mucosal healing and clinical remission in Polish pediatric patients with moderate-to-severe Crohn’s disease. European Journal of Gastroenterology & Hepatology. 24(5). 495–500. 41 indexed citations
14.
Manns, Michael P., Marek Woynarowski, Wolfgang Kreisel, et al.. (2010). Budesonide Induces Remission More Effectively Than Prednisone in a Controlled Trial of Patients With Autoimmune Hepatitis. Gastroenterology. 139(4). 1198–1206. 258 indexed citations
15.
Dzierżanowska‐Fangrat, Katarzyna, et al.. (2006). Hepatitis B virus genotypes in children with chronic hepatitis B in Poland. European Journal of Gastroenterology & Hepatology. 18(6). 655–658. 8 indexed citations
16.
17.
Gregorek, Hanna, Katarzyna Dzierżanowska‐Fangrat, Marek Woynarowski, et al.. (2005). [Persistence of hepatitis B virus in children after interferon-alpha therapy despite the seroconversion in HBsAg/anti-HBs system].. PubMed. 59(3). 641–9. 1 indexed citations
18.
Gregorek, Hanna, Katarzyna Dzierżanowska‐Fangrat, Marek Woynarowski, et al.. (2005). Persistence of HBV-DNA in children with chronic hepatitis B who seroconverted to anti-HBs antibodies after interferon-α therapy: correlation with specific IgG subclass responses to HBsAg. Journal of Hepatology. 42(4). 486–490. 13 indexed citations
19.
Gregorek, Hanna, et al.. (2000). IgG Subclass Distribution of Hepatitis B Surface Antigen Antibodies Induced in Children with Chronic Hepatitis B Infection after Interferon‐α Therapy. The Journal of Infectious Diseases. 181(6). 2059–2062. 14 indexed citations
20.
Gregorek, Hanna, et al.. (2000). The IgG subclass profile of anti-HBs response in vaccinated children and children seroconverted after natural infection. Vaccine. 18(13). 1210–1217. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fuad Hasan Breakdown of academic impact, for papers by Alberto Muñoz Breakdown of academic impact, for papers by Ranjana Gondal Breakdown of academic impact, for papers by Mustafa Yakut Breakdown of academic impact, for papers by Breanndan S. Moore Breakdown of academic impact, for papers by Mirta Ciocca Breakdown of academic impact, for papers by A. Elewaut Breakdown of academic impact, for papers by Mohammed Q. Khan Breakdown of academic impact, for papers by Gökhan Kabaçam Breakdown of academic impact, for papers by Zsuzsanna Vitális
Rankless by CCL
2026